HealthTech
Strand Therapeutics
Strand Therapeutics raises $153M Series B
$153M
Total Raised
Series B
Latest Round
2019
Founded
100+
Employees
Boston, MA
1 min read
Quick Facts
Latest Round Size
$153M
Latest Round Date
September 2025
Strand Therapeutics: Series B Funding Round
Strand Therapeutics has successfully raised $153M in Series B funding.
Company Overview
mRNA-based therapeutics developer with novel cancer treatment platform
Funding Details
The Series B round was led by Kinnevik.
Company Information
- Headquarters: Boston, MA
- Founded: 2019
- Employees: 100+
- Category: HealthTech
Investment
Strand Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Kinnevik: Verified investor in Series B
Key Investors
Kinnevik
Lead Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
DermaSensor
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Editorial Team
Oct 6, 2025
1 min read•$16M
HealthTech
Devoted Health Partners
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
Editorial Team
Oct 5, 2025
2 min read